I earned my PhD from the University of Wisconsin in 2008, focusing on the transformative role of genomics in personalized medicine. Over the past 15 years, I have led and advised strategic initiatives in medical communications for pharmaceutical and medical device companies, building expertise at the intersection of science, strategy, and commercialization. Today, I am applying this experience to help build a company focused on connecting cancer patients with clinical trials.